Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staccato alprazolam for stereotypical prolonged seizures
2021-002686-18Phase 3Active
- Sponsor
- UCB
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in status epilepticus (SE) and epilepsy comparing Staccato alprazolam with Placebo (2 arms). Primary endpoint: Treatment success for the treated seizure with no recurrence after 2 hours. Started Aug 2021; status: active.
02
Drugs
alprazolam
03
Conditions
status epilepticus (SE)epilepsy
Beyond the preview
Go deeper on 2021-002686-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002686-18.